摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrin | 1394285-02-9

中文名称
——
中文别名
——
英文名称
5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrin
英文别名
2-[(3,5-dimethyl-1H-pyrrol-2-yl)-(2,3,4,5,6-pentafluorophenyl)methylidene]-3,5-dimethylpyrrole
5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrin化学式
CAS
1394285-02-9
化学式
C19H15F5N2
mdl
——
分子量
366.334
InChiKey
RAQXQPZNTDYHMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.51
  • 重原子数:
    26.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    28.15
  • 氢给体数:
    1.0
  • 氢受体数:
    1.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrinN-溴代丁二酰亚胺(NBS)三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 生成 2,6-dibromo-8-pentafluorophenyl-1,3,5,7-tetramethyl-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
    参考文献:
    名称:
    卤代 3,5-二甲基- 和 1,3,5,7-四甲基-内消旋-五氟苯基 BODIPY 染料的光动力抗菌活性
    摘要:
    研究了四种内消旋五氟苯基 BODIPY 染料对金黄色葡萄球菌的光动力抗微生物化学疗法 (PACT) 活性,以确定与在 BODIPY 核心上引入不同取代基相关的结构-性质关系。合成并表征了在 2,6 位(2a和3a )具有溴和碘原子的 1,3,5,7-四甲基染料以及在 1,2,6 位被四溴化的 3,5-二甲基染料,7-位 ( 2b ) 或二碘化 ( 3b) 在 2,6-位置。相对于二溴和四溴染料,在 BODIPY 核心的 2,6 位加入碘原子增强了 PACT 活性。用质子取代 1,7-位的甲基形成3b导致比3a的情况更高的 PACT 活性,因为在 1,7-位不存在与甲基相关的空间位阻允许中间芳基环旋转更接近的平面π-BODIPY 核心系统。四溴化染料被发现具有最低的 PACT 活性,因为它在溶液中缺乏稳定性并且被研究的细菌吸收不良。选择吸电子的五氟苯基来降低 BODIPY 核心染料的偶极矩,因为在用硫代甲基苯基制备
    DOI:
    10.1142/s1088424622500535
  • 作为产物:
    描述:
    5-pentafluorophenyl-1,3,7,9-tetramethyldipyrromethane 在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以63%的产率得到5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrin
    参考文献:
    名称:
    二吡啶-铱(III)配合物在光动力治疗和抗菌光动力灭活中的应用
    摘要:
    生物靶向光敏剂的产生对于光动力疗法和抗菌(光)疗法的新兴领域至关重要。提出了一种合成策略,其中使用螯合二吡啉部分来增强铱(III)金属配合物的已知光活性。因此,形成的复合物可以通过一系列靶向基团在其化学活性反应位点以简便的方式进行官能化。具有 N- 和 O- 取代基的二吡啶通过与各自的 Cp*-铱(III) 和 ppy-铱(III) 前体络合得到 (dipy) 铱 (III) 络合物 (dipy=dipyrrinato, Cp*=pentamethyl-η 5 ‐环戊二烯基,ppy=2-苯基吡啶基)。类似地,缺电子的[Ir III (dipy)(ppy) 2 ]配合物可用于后官能化,形成烯基、炔基和糖基铱(III)配合物。这些复合物的光毒性活性已在有光和无光的细胞和细菌测定中进行了评估; [Ir III (Cl)(Cp*)(dipy)]配合物和糖取代的铱(III)配合物作为光医学候选者表现
    DOI:
    10.1002/chem.202004776
点击查看最新优质反应信息

文献信息

  • Optical limiting properties of D-π-A BODIPY dyes in the presence and absence of methyl groups at the 1,7-positions
    作者:Aviwe May、John Mack、Tebello Nyokong
    DOI:10.1142/s1088424620500315
    日期:2020.9

    The optical limiting properties of three meso-pentafluorophenylstyrylBODIPY dyes are investigated in the presence and absence of methyl groups at the 1,7-positions that hinder free rotation of the meso-aryl group. Pentafluorophenyl groups are introduced at the meso-position, while 4-diethylaminostyryl groups are introduced at the 3- and/or 5-positions to form dyes with strong donor-[Formula: see text]-acceptor (D-[Formula: see text]-A) properties to enhance the dipole moment of the molecule. Favorable optical limiting properties are obtained for all three dyes, with the highest second-order hyperpolarizability value obtained for a monostyryl dye with no methyl groups at the 1,7-position. Bromination at the 2,6-positions of a 1,7-methyl substituted dye is found to result in second-order hyperpolarizability that is an order of magnitude lower than that calculated for the analogous non-halogenated dye.

    在 1,7 位存在和不存在阻碍介芳基自由旋转的甲基的情况下,研究了三种介五氟苯苯乙烯-BODIPY 染料的光学限制特性。在中位引入了五氟苯基基团,而在 3-和/或 5-位引入了 4-二乙基苯乙烯基团,从而形成了具有强供体-[式:见正文]-受体(D-[式:见正文]-A)特性的染料,增强了分子的偶极矩。这三种染料都具有良好的光学限制特性,其中 1,7 位没有甲基的单苯乙烯染料的二阶超极化率值最高。研究发现,1,7-甲基取代染料的 2,6-位化会导致二阶超极化率,而二阶超极化率要比计算出的类似非卤化染料的二阶超极化率低一个数量级。
  • Synthesis and characterisation of neutral mononuclear cuprous complexes based on dipyrrin derivatives and phosphine mixed-ligands
    作者:Xiaohui Liu、Hongmei Nan、Wei Sun、Qikai Zhang、Mingjian Zhan、Luyi Zou、Zhiyuan Xie、Xiao Li、Canzhong Lu、Yanxiang Cheng
    DOI:10.1039/c2dt30618b
    日期:——
    Heteroleptic neutral mononuclear cuprous complexes with dipyrrin derivatives and phosphine mixed-ligands including 1,3,7,9-tetramethyldipyrrin (1), 5-phenyl-1,3,7,9-tetramethyldipyrrin (2), 2,8-dibromo-1,3,7,9-tetramethyldipyrrin (3), 1,9-dichloro-5-phenyldipyrrin (4), 1,9-dibromo-5-phenyldipyrrin (5), 5-pentafluorophenyl-1,3,7,9-tetramethyldipyrrin (6) and 1,5,9-triphenyldipyrrin (7) have been synthesized and fully characterized. The central Cu(I) atoms of these complexes in general formulas of Cu(1–6)(PPh3)2 (1a–6a) and Cu(1–6)(DPEphos) (1b–6b) [DPEphos = bis(2-diphenylphosphinophenyl)ether] all exhibit a pseudo-tetrahedral geometry, while complex Cu(7)(PPh3) (7a) is tricoordinated in a pyramidal conformation due to the large steric hindrance of ligand 7. The oxidation potentials assigned to oxidations of Cu(I)–Cu(II) are extraordinarily low in the range of 0.36–1.02 V vs. Ag/AgCl compared with traditional [Cu(phen)(PP)]+ analogues. Their emission maxima range from 495 to 595 nm in dichloromethane at room temperature with quantum yields of 0.05–4.03% and lifetimes on the order of nanoseconds. Unlike the characteristic MLCT emission in cationic Cu(I) complexes, the emissions are assigned to the dipyrrin-centered intraligand charge transition (ILCT) based on the fact that the increased conjugation within the dipyrrinato anion leads to a weaker metal–ligand interaction, thus preventing the mixing of π orbitals of ligand and 3d orbitals of Cu(I) atom. This conclusion is also supported by electrochemical data and theoretical calculations.
    合成了一系列含有二吡咯甲川衍生物和膦混合配体的杂配位中性单核亚配合物,并用 1,3,7,9-四甲基二吡咯甲川(1)、5-苯基-1,3,7,9-四甲基二吡咯甲川(2)、2,8-二-1,3,7,9-四甲基二吡咯甲川(3)、1,9-二-5-苯基二吡咯甲川(4)、1,9-二-5-苯基二吡咯甲川(5)、5-(五氟苯基)-1,3,7,9-四甲基二吡咯甲川(6)和1,5,9-三苯基二吡咯甲川(7)进行了全面表征。这些配合物的中心Cu(I)原子通常具有伪四面体几何构型,通式为Cu(1~6)(PPh3)2(1a~6a)和Cu(1~6)(DPEphos)(1b~6b)[DPEphos=二(2-二苯基膦苯基)醚],而配体7由于空间位阻较大,使得配合物Cu(7)(PPh3)(7a)表现出三角锥形的结构。与传统的[Cu(phen)(PP)]+类似物相比,这些配合物中Cu(I)到Cu(II)的氧化电位在0.36至1.02 V(vs. Ag/AgCl)的范围内异常低。它们在室温下的二氯甲烷中的最大发射波长范围为495至595 nm,量子产率为0.05至4.03%,寿命为纳秒级。与阳离子Cu(I)配合物中的特征MLCT发射不同,这些配合物的发射被归因于二吡咯甲川中心的配体内电荷跃迁(ILCT),这是因为二吡咯甲川阴离子内部共轭程度的增加导致属与配体之间的相互作用减弱,从而阻止了配体π轨道与Cu(I)原子的3d轨道的混合。这一结论也得到了电化学数据和理论计算的支持。
  • PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL SENSOR, AND IMAGING ELEMENT
    申请人:FUJIFILM Corporation
    公开号:US20200035932A1
    公开(公告)日:2020-01-30
    The present invention provides a photoelectric conversion element exhibiting excellent responsiveness, and excellent dark current characteristics in a case of high-speed photoelectric conversion film formation, an optical sensor, an imaging element, and a compound which include the photoelectric conversion element. The photoelectric conversion element of the present invention includes a conductive film, a photoelectric conversion film, and a transparent conductive film, in this order, in which the photoelectric conversion film contains a compound represented by Formula (1), and an n-type organic semiconductor having a predetermined structure.
    本发明提供了一种光电转换元件,其在高速光电转换薄膜形成的情况下表现出优异的响应性和优秀的暗电流特性,以及包括该光电转换元件的光学传感器、成像元件和化合物。本发明的光电转换元件包括一个导电膜、一个光电转换膜和一个透明导电膜,按照这个顺序排列,其中光电转换膜含有一个由式(1)表示的化合物和一个具有预定结构的n型有机半导体。
  • Spectroscopic, computational modeling and cytotoxicity of a series of meso-phenyl and meso-thienyl-BODIPYs
    作者:Jaime H. Gibbs、Larry T. Robins、Zehua Zhou、Petia Bobadova-Parvanova、Michael Cottam、Gregory T. McCandless、Frank R. Fronczek、M. Graça H. Vicente
    DOI:10.1016/j.bmc.2013.07.017
    日期:2013.9
    A series of twenty-two BODIPY compounds were synthesized, containing various meso-phenyl and meso-thienyl groups, and their spectroscopic and structural properties were investigated using both experimental and computational methods. Further functionalization of the BODIPY framework via iodination at the 2,6-pyrrolic positions was explored in order to determine the effect of these heavy atoms on the photophysical and cytotoxicity of the meso-aryl-BODIPYs. BODIPYs bearing meso-thienyl substituents showed the largest red-shifted absorptions and emissions and reduced fluorescence quantum yields. The phototoxicity of the BODIPYs in human carcinoma HEp2 cells depends on both the presence of iodines and the nature of the meso-aryl groups. Six of the eleven 2,6-diiodo-BODIPYs investigated showed at least a sevenfold enhancement in phototoxicity (IC50 = 3.5-28 mu M at 1.5 J/cm(2)) compared with the non-iodinated BODIPYs, while the others showed no cytotoxicity, while their singlet oxygen quantum yields ranged from 0.02 to 0.76. Among the series investigated, BODIPYs 2a and 4a bearing electron-donating meso-dimethoxyphenyl substituents showed the highest phototoxicity and dark/phototoxicity ratio, and are therefore the most promising for application in PDT. (C) 2013 Elsevier Ltd. All rights reserved.
  • Synthesis and photo-physical properties of a series of BODIPY dyes
    作者:Stefano Banfi、Gianluca Nasini、Stefano Zaza、Enrico Caruso
    DOI:10.1016/j.tet.2013.04.064
    日期:2013.6
    A series of 39 boron-dipyrrolylmethenes (BODIPYs) have been synthesized and characterized. Their spectroscopic properties, degree of lipophilicity, chemical stability under irradiation, and singlet-oxygen generation rate have also been studied. These compounds differ in the presence of ethyl groups (group A), hydrogens (group B) or iodines (group C) on the 2,6 positions; these appendices confer particular characteristics to each group. The presence of an aromatic substituent or hydrogen on the indacene 8 position produces 13 different molecules of each group. Besides the effects exerted by the group or atom on the 2,6 positions, the substituent on the 8 position exerts a further effect on the physico-chemical parameters, thus the desired properties of BODIPYs, concerning fluorescence, lipophilicity, and singlet oxygen production can be modulated accordingly. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫